Is CPRX a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Catalyst Pharmaceuticals Inc (CPRX) is 37.25 USD. With the latest stock price at 24.23 USD, the upside of Catalyst Pharmaceuticals Inc based on DCF is 53.8%. This means that CPRX is a buy according to the DCF valuation model.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 7.6% | 6.5% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 27.44 - 64.92 | 37.25 |
| Upside | 13.3% - 168.0% | 53.8% |